These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6212205)

  • 21. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
    Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH
    Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
    Rolfe RD; Finegold SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Thompson RL; Fisher KA; Wenzel RP
    Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA; LeFrock JL; Vercler MJ
    Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
    Horadam VW; Smilack JD; Montgomery CL; Werringloer J
    Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1981 Dec; 20(6):841-2. PubMed ID: 7034644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Owens WE; Finegold SM
    Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS; Neu HC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli.
    Fass RJ
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1003-6. PubMed ID: 6810755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 May; 17(5):884-9. PubMed ID: 6772097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-formimidoyl thienamycin (MK0787): in vitro study.
    Shadomy S; May RS
    Antimicrob Agents Chemother; 1981 Jan; 19(1):201-4. PubMed ID: 6941741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-formimidoyl-thienamycin a novel beta-lactam: an in-vitro comparison with other beta-lactam antibiotics.
    Wise R; Andrews JM; Patel N
    J Antimicrob Chemother; 1981 May; 7(5):521-9. PubMed ID: 6790507
    [No Abstract]   [Full Text] [Related]  

  • 36. The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.
    Tischhauser G; Kayser FH
    Infection; 1983; 11(4):219-26. PubMed ID: 6578202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.
    Wise R; Andrews JM; Danks G
    Antimicrob Agents Chemother; 1983 Dec; 24(6):909-14. PubMed ID: 6607032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of 523 blood culture isolates to 33 antibiotics.
    Ode B; Forsgren A; Walder M
    Scand J Infect Dis; 1984; 16(1):61-71. PubMed ID: 6559413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
    Dornbusch K; Adamsson L; Gezelius L; Hallander H
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.